NEO
NeoGenomics Inc
18.40$
-2.8%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.4% | +0.4% | +5.3% | +2.0% | +2.5% | -2.3% | +7.9% | +3.6% | +1.3% | -1.8% | +8.0% | – | |
| – | -1.9% | +3.2% | +1.4% | +1.0% | +1.9% | +0.0% | +9.8% | +3.2% | +6.6% | -7.6% | +3.8% | – | |
| – | +8.5% | -3.1% | +10.7% | +3.3% | +3.2% | -5.2% | +5.5% | +4.1% | -5.9% | +6.8% | +13.6% | – | |
| – | +34.9% | +6.9% | +3.5% | -2.6% | +3.7% | +27.8% | -11.4% | -3.6% | +5.6% | +3.9% | +12.9% | – | |
| – | -2.8% | +10.1% | -3.8% | +5.7% | -5.0% | +2.5% | +10.0% | -2.6% | -9.1% | +3.5% | -3.2% | – | |
| – | -0.4% | +11.5% | -1.7% | +1.7% | -0.4% | +5.7% | +23.6% | -14.0% | -19.2% | +14.1% | +2.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -0.2% | +0.2% | -1.1% | -1.4% | -1.1% | -0.4% | -42.3% | -35.4% | -0.7% | -0.2% | +30.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | -372.2% | – | -441.2% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -262.5% | – | +135.2% | +107.2% | -271.3% | – | – | – | -112.4% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.